TXMD - TherapeuticsMD Inc
IEX Last Trade
1.91
0.030 1.571%
Share volume: 5,267
Last Updated: Fri 30 Aug 2024 07:45:47 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.88
0.03
1.60%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-16 | 2022-08-15 | 2022-11-14 | 2023-04-07 | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-03-29 | |
| Total revenue | 19.333 M | 28.561 M | 20.917 M | 1.152 M | 416.000 K | 437.000 K | 0.000 | 449.000 K | |
| Cost of revenue | 4.860 M | 4.740 M | 3.788 M | -11.991 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 14.473 M | 23.821 M | 17.129 M | 13.143 M | 416.000 K | 437.000 K | 0.000 | 449.000 K | |
| 64.59% | -28.09% | -23.27% | -96.83% | 5.05% | -100.00% | inf% | |||
| Operating expenses | 40.702 M | 42.662 M | 37.876 M | -63.337 M | 3.056 M | 2.781 M | 1.590 M | 1.476 M | |
| Selling general and admin | 39.302 M | 41.082 M | 36.764 M | -59.245 M | 3.056 M | 2.781 M | 1.590 M | 1.476 M | |
| Research and development | 1.400 M | 1.580 M | 1.112 M | -4.092 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 45.562 M | 47.402 M | 41.664 M | -75.328 M | 3.083 M | 2.909 M | 1.773 M | 2.060 M | |
| 4.04% | -12.10% | -280.80% | 104.09% | -5.64% | -39.05% | 16.19% | |||
| Operating income | -26.229 M | -18.841 M | -20.747 M | 76.480 M | -2.667 M | -2.472 M | -1.773 M | -1.611 M | |
| Ebit | -26.229 M | -18.841 M | -20.747 M | 76.480 M | -2.667 M | -2.472 M | -1.773 M | -1.611 M | |
| Pretax income | -49.021 M | 112.831 M | -25.692 M | -37.044 M | -2.310 M | -2.414 M | -1.434 M | -1.584 M | |
| -330.17% | -122.77% | 44.18% | -93.76% | 4.50% | -40.60% | 10.46% | |||
| Income tax | 0.000 | 550.000 K | -260.000 K | -290.000 K | 0.000 | 0.000 | 0.000 | -43.000 K | |
| Net income basic | -49.021 M | 112.281 M | -28.965 M | 77.702 M | -3.603 M | -2.414 M | -3.378 M | -883.000 K | |
| 329.05% | -125.80% | 368.26% | -104.64% | 33.00% | -39.93% | 73.86% | |||
| Net income | -49.021 M | 112.281 M | -28.965 M | 77.702 M | -3.603 M | -2.414 M | -3.378 M | -883.000 K | |
| 329.05% | -125.80% | 368.26% | -104.64% | 33.00% | -39.93% | 73.86% |